Current Challenges in Cardiovascular Risk Reduction in the Setting of T2D and ACS A. Michael Lincoff, MD - Program Chairman
Navigating and Understanding the Pathobiologic Interfaces of Diabetes and Atherosclerotic Heart Disease Jorge Plutzky, MD
Deciphering the Maze of Evidence Illuminating the Role of Glycemic Regulation and Insulin Resistance on Cardiovascular Risk—What Should Our Goals and Biomarker Targets Be? Richard Nesto, MD
The Role of Lipid Management in the Post-ACS Setting in Patients with Diabetes—Goals, Results, and Clinical Implications Michael Davidson, MD
The Evolving Role of PPAR Agonists for Cardiovascular and Stroke Risk Reduction in the Diabetic Patient with a History of Acute Coronary Syndrome (ACS) A. Michael Lincoff, MD - Program Chairman
Question and Answer Interactive Session Faculty Panel
